Clinical trial
Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus…
NCT00197522 · Hamilton Health Sciences Corporation, Other · Completed
Key facts
| NCT number | NCT00197522 |
|---|---|
| Title | Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2 |
| Official title | A Phase I Study Investigating Multiple Injections of Autologous CD34+ Derived Dendritic Cells Transduced With an Adenovirus Vector Expressing Inactivated HER-2/Neu in Patients With Metastatic Breast Cancer |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | Ontario Cancer Research Network Canadian Breast Cancer Research Alliance McMaster University |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Biological |
| Interventions | CD34+ derived DCs |
| Enrollment | 5 |
| Start date | Oct 1, 2004 |
| Primary completion | May 1, 2012 |
| Completion | May 1, 2012 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 1, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: